Clinuvel Pharmaceuticals Ltd (CUV) — Capital Reinvestment Ratio
Clinuvel Pharmaceuticals Ltd (CUV) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$12.52 Million) in capital expenditures (AU$149.47K). See how leveraged is Clinuvel Pharmaceuticals Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Clinuvel Pharmaceuticals Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Clinuvel Pharmaceuticals Ltd's Capital Reinvestment Ratio across 9 annual periods. Check total reinvestment intensity of Clinuvel Pharmaceuticals Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Clinuvel Pharmaceuticals Ltd from 2017 to 2025. For live market cap and broader valuation context, see CUV market cap.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | AU$41.10 Million | AU$298.57K | ▼ -95.2% |
| 2024 | 0.15x | AU$37.05 Million | AU$5.58 Million | ▲ +440.6% |
| 2023 | 0.03x | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.01x | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.04x | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.06x | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.01x | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$9.92 Million | AU$67.48K | — |